corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Favourite items of

Page 1 of 206 pages  1 2 3 >  Last ›

HSL20592
Wegwarth O, Gigerenzer G
Overdiagnosis and Overtreatment: Evaluation of What Physicians Tell Their Patients About Screening Harms
JAMA Internal Med 2013 Dec173:(22):2086-2087
http://archinte.jamanetwork.com/article.aspx?articleID=1754987

HSL20591
Schwitzer G
When doctors don’t discuss harms of screening tests with patients
Health New Review.org 2013 Oct 22
http://www.healthnewsreview.org/2013/10/when-doctors-dont-discuss-harms-of-screening-tests-with-patients/

HSL20593
Unreliable research: Trouble at the lab
The Economist 2013 Oct 19

HSL20585
Ubel PA, Abernethy AP, Zafar SY
Full Disclosure - Out-of-Pocket Costs as Side Effects
NEJM 2013 Oct 17369:
http://www.nejm.org/doi/full/10.1056/NEJMp1306826

HSL20586
Wen L
What Do You Know About Your Doctor?
Psychology Today 2013 Oct 15
http://www.psychologytoday.com/blog/the-doctor-is-listening/201310/what-do-you-know-about-your-doctor

HSL20587
Blumer C
Ethical Triage For Doctors
The Globe and Mail 2013 Oct 15
http://www.theglobalmail.org/blog/ethical-triage-for-doctors/710/

HSL20588
Bertens LCM, Broekhuizen BDL, Naaktgeboren CA, Rutten FH, Hoes AW, van Mourik Y, Moons KGM, Reitsma JB
Use of Expert Panels to Define the Reference Standard in Diagnostic Research: A Systematic Review of Published Methods and Reporting
PLoS Med 2013 Oct 1510:(10):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001531

HSL20589
Blumer C
Medical Ethics Under The Knife
The Global Mail 2013 Oct 9
http://www.theglobalmail.org/feature/medical-ethics-under-the-knife/707/

HSL20590
Arie S
Doctors’ groups are criticised for endorsing pro-industry guidelines
BMJ 2013 Oct 9347:
http://www.bmj.com/content/347/bmj.f6066

HSL20584
Taylor L
Serious side-effects warnings can increase drug sales: study
PharmaTimes 2013 Sep 24
http://www.pharmatimes.com/Article/13-09-24/Serious_side-effects_warnings_can_increase_drug_sales_study.aspx

HSL20583
Bowie C
Sales reps struggling with the new NHS environment
Pharma Times 2013 Aug 30
http://www.pharmatimes.com/Article/13-08-30/Sales_reps_struggling_with_the_new_NHS_environment.aspx

HSL20581
Burns M
Report profiles cardiologists for market insights
Pharmalive 2013 Aug 29
http://www.pharmalive.com/report-profiles-cardiologists-for-market-insights

HSL20580
Moynihan RN, Cooke GPE, Doust JA, Bero L, Hill S, Glasziou PP
Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States
PLoS Med 2013 Aug 13
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001500

HSL20578
Cavicchi V
Defining the Audience: Customer-Centric Sales Strategies and Physician Segmentation
Cutting Edge Info 2013 July 24
http://www.cuttingedgeinfo.com/2013/defining-audience-customer-centric-sales-strategies-physician-segmentation/

HSL20575
Fern Tay H
Chinese police accuse GlaxoSmithKline of artificially inflating cost of medicine
PM : ABC Radio National 2013 July 180
http://www.abc.net.au/pm/content/2013/s3806244.htm

HSL20574
Yan A, Han Shih T
Shanghai travel agent's revenue surge led to arrests in GSK bribery case
South China Post 2013 July 16
http://www.scmp.com/news/china/article/1283207/glaxosmithkline-suspects-drug-bribery-probe-identified

HSL20573
Trans-Pacific trade agreement could choke off patient access to affordable generic medicines
Medicines Sans Frontiers 2013 July 15
http://www.msfaccess.org/about-us/media-room/press-releases/trans-pacific-trade-agreement-could-choke-patient-access

HSL20577
Nagarajan R
The patient doctor
The Times of India 2013 July 6
http://www.timescrest.com/coverstory/the-patient-doctor-10659

HSL20571
Burns M
Study unearths ‘surprising’ findings on doctors’ good publication practice views
Pharmalive 2013 Jun 26
http://www.pharmalive.com/study-unearths-‘surprising’-findings-on-doctors’-good-publication-practice-views

HSL20579
Wise J
Novartis found to be in breach of code over drug brochure
BMJ 2013 Jun 20346:
http://www.bmj.com/content/346/bmj.f4061

HSL20568
Davies E
Flu hype and pharma failures: patients deserve better
BMJ 2013 May 24346:
http://www.bmj.com/content/346/bmj.f3422

HSL20561
Eban K
The latest to claim fraud at generic Lipitor maker Ranbaxy: Its owners
CNN Money 2013 May 23
http://features.blogs.fortune.cnn.com/2013/05/23/ranbaxy-lipitor-fraud/

HSL20562
Harvey K, Voevodin M
Regulations around food-medicine products fail to protect consumers
The Conversation 2013 May 21
https://theconversation.com/regulations-around-food-medicine-products-fail-to-protect-consumers-14360

HSL20570
Davies E
Can Big Pharma put patients first?
BMJ 2013 May 21346:
http://www.bmj.com/content/346/bmj.f3285

HSL20560
Govt to regulate rates of 652 medicines; prices set to fall
Economic Times 2013 May 17
http://articles.economictimes.indiatimes.com/2013-05-17/news/39336744_1_essential-drugs-price-control-indian-pharmaceutical-alliance

HSL20569
Doshi P
Influenza: marketing vaccine by marketing disease
BMJ 2013 May 16346:
http://www.bmj.com/content/346/bmj.f3037

HSL20559
Tiefer L, Witczak K, Heath I
A call to challenge the 'Selling of Sickness'
BMJ 2013 May 14346:f2809 doi: http://dx.doi.org/10.1136/bmj.f2809
http://www.bmj.com/content/346/bmj.f2809

HSL20563
Corderoy A
Most pills and potions fail the test
The Sydney Morning Herald 2013 May 12
http://www.smh.com.au/national/health/most-pills-and-potions-fail-the-test-20130511-2jeji.html

HSL20564
Corderoy A
War of words on potions and pills continues
The Sydney Morning Herald 2013 May 12
http://www.smh.com.au/national/health/war-of-words-on-potions-and-pills-continues-20130511-2jely.html

HSL20558
Rome E
Big Pharma CEOs Rake in $1.57 Billion in Pay
The Huffington Post 2013 May 8
http://www.huffingtonpost.com/ethan-rome/big-pharma-ceo-pay_b_3236641.html

HSL20565
McCredie J
Jane McCredie: A drop of credibility
MJA InSight 2013 May 6
https://www.mja.com.au/insight/2013/16/jane-mccredie-drop-credibility

HSL20566
Ed.
Exorbitant Prices for Leukemia Drugs
The New York Times 2013 May 1
http://www.nytimes.com/2013/05/02/opinion/exorbitant-prices-for-cancer-drugs.html?_r=0

HSL20551
How Big Pharma Is Killing Americans
Truthout 2013 Apr 29
http://truth-out.org/opinion/item/16071-how-big-pharma-is-killing-americans

HSL20531
Rosenberg M
6 New Ways Big Pharma Is Scheming to Make Billions at the Expense of Your Health
Alternet 2013 Apr 25
http://www.alternet.org/personal-health/6-new-ways-big-pharma-scheming-make-billions-expense-your-health?paging=off

HSL20532
J.D. Power study shows physicians still see reps as main influence
Pharmalive 2013 Apr 25
http://www.pharmalive.com/jd-power-and-associates-reports-that-relationship-marketing-still-matters-in-oncology-pharma-sales

HSL20530
US govt sues Novartis for health care fraud
The Indian Express 2013 Apr 24
http://m.indianexpress.com/news/us-govt-sues-novartis-for-health-care-fraud/1106948/

HSL20501
Indian Supreme Court Delivers Verdict in Novartis Case
Medicines Sans Frontiers 2013 Apr 1
http://www.msfaccess.org/about-us/media-room/press-releases/indian-supreme-court-delivers-verdict-novartis-case

HSL20495
Ed.
Getting Closer to a Fully Correctable and Connected Research Literature
PLoS Med 2013 Mar 2610:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001408?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosmedicine%2FNewArticles+%28Ambra+-+Medicine+New+Articles%29

HSL20496
Ana J, KoehlmoosT, Smith R, Yan LL
Research Misconduct in Low- and Middle-Income Countries
PLoS Med 2013 Mar 2610:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001315

HSL20497
Resnik DB, Master Z
Policies and Initiatives Aimed at Addressing Research Misconduct in High-Income Countries
PLoS Med 2013 Mar 2610:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001406?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosmedicine%2FNewArticles+%28Ambra+-+Medicine+New+Articles%29

HSL20498
Svensson S, Menkes DB, Lexchin J
Surrogate Outcomes in Clinical Trials: A Cautionary Tale
JAMA 2013 Mar 25(1-2 ):
http://archinte.jamanetwork.com/article.aspx?articleid=1672283

HSL20493
Sharp C
Key Opinion Leaders – A Fast and Furious Approach to Brand Recognition
eyeforpharma 2013 Mar 21
http://social.eyeforpharma.com/sales-marketing/key-opinion-leaders-mclaren-content-marketing-barcelona

HSL20462
Brauser D
Psychiatrists Top List of Big Pharma Payments Again
Medscape 2013 Mar 14
http://www.medscape.com/viewarticle/780835

HSL20461
Kmietowicz Z
BMA follows Lancet in quitting group on collaboration between doctors and drug industry
BMJ 2013 Mar 8346:
http://dx.doi.org/10.1136/bmj.f1574

HSL20455
'Bayer’s Tonic' still on the Market
Coalition against Bayer Dangers 2013 Mar 5
www.CBGnetwork.org

HSL20458
Bramwell N
TGA reform delays slammed
Medical Observer 2013 Mar 5
http://www.medicalobserver.com.au/news/tga-reform-delays-slammed

HSL20492
Wood M
Sales Excellence in the Pharma Industry: An Interview with Hoffmann-La Roche’s Michael van Olm
eyeforpharma 2013 Mar 4
http://social.eyeforpharma.com/sales-marketing/sales-excellence-pharma-roche-michael-van-olm-interview

HSL20456
Cymbalta still tops in U.S. drug promotion list
Med Ad News 2013 Feb 28
http://blog.medadnews.com/index.php/2013/02/28/cymbalta-still-tops-in-u-s-drug-promotion-list/

HSL20457
Kaye B
Senate bill to ban pharma freebies
Medical Observer 2013 Feb 28
http://www.medicalobserver.com.au/news/senate-bill-to-ban-pharma-freebies

HSL20460
Blumer C, Seccombe M
Who’s Your Doctor Dining With? (And Why You Should Care)
The Global Mail 2013 Feb 28
http://powerhouse.theglobalmail.org/whos-your-doctor-dining-with-and-why-you-should-care/

HSL20459
Pirri C
Embracing CAM
MJA InSight 2013 Feb 25
http://www.mjainsight.com.au/view?post=carlo-pirri-embracing-cam&post_id=12270&cat=comment&mo=1

HSL20470
Burns M
Manhattan Research: Pharma widens target to new decision makers
Med Ad News 2013 Feb 11
http://blog.medadnews.com/index.php/2013/02/11/pharma-widens-target-to-new-decision-makers/

HSL20452
Kmietowicz Z
GSK backs campaign for disclosure of trial data
BMJ 2013 Feb 7346:
http://www.bmj.com/content/346/bmj.f819

HSL20453
Roehr B
Drug companies will have to report all payments to US doctors from March 2014
BMJ 2013 Feb 7346:
http://www.bmj.com/content/346/bmj.f826

HSL20451
Davis C
Is there a cure for corporate crime in the drug industry?
BMJ 2013 Feb 6346:
http://www.bmj.com/content/346/bmj.f755

HSL20454
Tucker ME
Drug companies lobby against generic versions of biologics
BMJ 2013 Feb 4346:
http://www.bmj.com/content/346/bmj.f740

HSL20450
Horton R
Offline: Falling out with pharma
The Lancet 2013 Feb 2381:(9864):358
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2960139-7/fulltext

HSL20449
Kanter J, Thomas K
European Officials Say Drug Makers Paid to Delay Generic Version
The New York Times 2013 Jan 31
http://www.nytimes.com/2013/02/01/business/global/eu-says-drug-makers-paid-to-delay-generic-version.html?smid=tw-nytimeshealth&seid=auto&_r=1&

HSL20481
Ed.
Getting More Generous with the Truth: Clinical Trial Reporting in 2013 and Beyond
PLoS Med 2013 Jan 2910:(1):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001379

HSL20482
Vedula SS, Li T, Dickersin K
Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
PLoS Med 2013 Jan 2910:(1):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001378

HSL20448
Doherty B
Drug companies 'using Indians as guinea pigs'
The Sydney Morning Herald 2013 Jan 27
http://www.smh.com.au/world/drug-companies-using-indians-as-guinea-pigs-20130126-2dduh.html?skin=text-only

HSL20447
Entry prices for new medications fall 35%
brasil.gov.br 2013 Jan 22
http://www.brasil.gov.br/news/history/2013/01/22/entry-prices-for-new-medications-fall-35/newsitem_view?set_language=en

HSL20471
Duijnhoven RG, Straus SMJM, Raine JM, de Boer A, Hoes AW, De Bruin ML
Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis
PLoS Med 2013
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001407

HSL20542
Lopert R, Gleeson D
The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines
The Journal of Law, Medicine & Ethics 201341:(1):199–223
http://onlinelibrary.wiley.com/doi/10.1111/jlme.12014/abstract

HSL20572
Brougher J
Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements
Journal of Commerical Biotechnology 201319:(3): doi: http://dx.doi.org/10.5912/jcb614
http://commercialbiotechnology.com/index.php/jcb/article/view/614

HSL20576
Light DW
Risky Drugs: Why The FDA Cannot Be Trusted
Journal of Law, Medicine and Ethics 2013
http://www.ethics.harvard.edu/lab/blog/312-risky-drugs

HSL20446
Roehr B
Eli Lilly settles corrupt foreign practices complaint for $29.4m
BMJ 2012 Dec 27345:e8694
http://www.bmj.com/content/345/bmj.e8694

HSL20443
Sinha K
Govt to crack down on pharma-doctor nexus
Times of India 2012 Dec 26
http://articles.timesofindia.indiatimes.com/2012-12-26/india/36007441_1_drug-companies-drug-promotion-dcgi

HSL20442
Rodwin MA
Independent Clinical Trials to Test Drugs: The Neglected Reform
Saint Louis University Journal of Health Law & Policy 2012 Dec 246:(12-58):113
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2193594

HSL20500
Ray K
Doc’s plaint stops vaccine ad on TV
The Deccan Herald 2012 Dec 14
http://www.deccanherald.com/content/298660/docs-plaint-stops-vaccine-ad.html

HSL20444
Boumil MM
Off-Label Marketing and the First Amendment
NEJM 2012 Dec 12368:103-105
http://www.nejm.org/doi/full/10.1056/NEJMp1214926

HSL20445
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L
Industry sponsorship and research outcome
The Cochrane Library 2012 Dec 12(12):
http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000033.pub2/full

HSL19717
Segatto C
O real risco das novas pílulas
Época 2012 Dec 9
http://revistaepoca.globo.com/Saude-e-bem-estar/noticia/2011/12/o-real-risco-das-novas-pilulas.html

HSL20499
Hegde BM
Money is Mammon in pharmaceutical world
The Hindu 2012 Dec 9
http://www.thehindu.com/opinion/open-page/money-is-mammon-in-pharmaceutical-world/article4179010.ece

HSL20438
AstraZeneca’s cancer drug patent rejected
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295062/astrazenecas-cancer-drug-patent-rejected.html

HSL20439
Medicines for needy
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295055/medicines-needy.html

HSL20440
Kumar C
Govt pact with generic drug seller ‘illegal’
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295090/govt-pact-generic-drug-seller.html

HSL20441
Swan N
The High Costs of Pharmaceuticals in Australia
Health Report : Radio National 2012 Nov 260
http://www.abc.net.au/radionational/programs/healthreport/the-high-costs-of-pharmaceuticals-in-australia/4392196#transcript

HSL20432
Srinivasan S
Is the shift away from cost-plus drug pricing desirable? - NO
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-no/article4127203.ece?homepage=true

HSL20433
Shah DG
Is the shift away from cost-plus drug pricing desirable? - YES
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-yes/article4127199.ece?homepage=true

HSL20434
Ferner R
A short history of pharmaceutical marketing
BMJ 2012 Nov 20345:e7801
http://www.bmj.com/content/345/bmj.e7801

HSL20435
Karmali N
India's Pharma Kings Are The Country's Big Winners
Forbes 2012 Oct 25
http://www.forbes.com/sites/naazneenkarmali/2012/10/25/indias-pharma-kings-are-the-countrys-big-winners/

HSL20437
Devinney T
Integrity pays dividends: the case for minding your own business
The Conversation 2012 Oct 25
http://theconversation.edu.au/integrity-pays-dividends-the-case-for-minding-your-own-business-9301

HSL20436
Preston C, Valdez M, Bond K
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
PLoS Med 2012 Oct 239:(10):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001327

HSL20422
Joelving F
Exclusive: Abbott suspends giving gifts to doctors in India
Reuters 2012 Oct 16
http://www.reuters.com/article/2012/10/16/us-abbott-india-doctors-idUSBRE89F1N820121016

HSL20421
Lewis H
Lies, damn lies and drug trials
New Statesman 2012 Oct 4
http://www.newstatesman.com/sci-tech/sci-tech/2012/10/lies-damn-lies-and-drug-trials

HSL20282
Supreme Court asks Centre not to alter pricing system for essential drugs
The Economic Times 2012 Oct 3
http://articles.economictimes.indiatimes.com/2012-10-03/news/34238803_1_essential-medicines-prices-control-steep-hike

HSL20284
Reynolds M
Australian Pharma companies bow to demanding doctors
6minutes.com 2012 Oct 2
http://www.6minutes.com.au/news/latest-news/transparency-will-expose-demanding-doctors

HSL20261
Thomas C
Medical journals: 'information-laundering for Big Pharma'?
The Ethical Nag 2012 Sep 26
http://ethicalnag.org/2012/09/26/medical-journals-information-laundering-big-pharma/

HSL20258
Luthra S
U. forgoes action against prof after study fraud
The Brown Daily Herald 2012 Sep 14
http://www.browndailyherald.com/u-forgoes-action-against-prof-after-study-fraud-1.2762909#.UFrj5I51A21

HSL20257
Bates A
How to Get More Sales from Your Sales Force Efforts
eyeforpharma 2012 Sep 4
http://social.eyeforpharma.com/column/how-get-more-sales-your-sales-force-efforts

HSL20402
Djulbegovic B, Hozo I, Beckstead J, Tsalatsanis A, Pauker SG
Dual processing model of medical decision-making
BMC Medical Informatics and Decision Making 2012 Sep 312:(94):
http://www.biomedcentral.com/1472-6947/12/94/abstract

HSL20259
Lee M, Hirschler B
China's 'wild east' drug store
Reuters 2012 Aug 28
http://uk.reuters.com/article/2012/08/28/uk-china-pharmaceuticals-idUKBRE87R0OE20120828

HSL20260
Light DW, Lexchin JR
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012 Aug 11
http://www.bmj.com/content/345/bmj.e4348

HSL20262
Harvey K
TGA failure gives Nurofen consumers a headache
The Conversation 2012 Aug 10
http://theconversation.edu.au/tga-failure-gives-nurofen-consumers-a-headache-8762

HSL20263
Bita N
Pharmaceutical companies spends $30m wining, dining doctors
The Australian 2012 Aug 10
http://www.theaustralian.com.au/news/health-science/pharmaceutical-companies-spends-30m-wining-dining-doctors/story-e6frg8y6-1226447086707

HSL20253
Unnikrishnan C
Doctors' freebies to be taxed
Times of India 2012 Aug 7
http://articles.timesofindia.indiatimes.com/2012-08-07/mumbai/33081949_1_freebies-pharma-firms-organization-of-pharmaceutical-producers

HSL20255
Kesselheim AS, Wang B, Studdert DM, Avorn J
Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
PLoS Med 2012 Aug 79:(8):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001280

HSL20314
Jones MI
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2012 Aug 4323:1-7
http://www.bmj.com/content/323/7309/378.1

HSL20249
Barker A
EU to charge two drugmakers over generics
The Financial Times 2012 July 25
http://www.ft.com/intl/cms/s/0/d9ce8402-d671-11e1-bd9c-00144feabdc0.html#axzz21t7yPXo0

Page 1 of 206 pages  1 2 3 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963